The Advisor Finder Report: Q1 2026
Welcome to the Q1 2026 issue of The Advisor Finder Report, a quarterly publication that surfaces the activity occurring on…
Surprise, the frictionless economy is here. Is your company ready for the future, or still stuck in the 20th century?
Business Insights
Transaction Toolbox
Middle Market Move of the Week
NeoGenomics, a clinical lab specializing in cancer genetics diagnostic testing, announced it would acquire Clarient Inc., a cancer diagnostic testing firm and GE subsidiary. The Wall Street Journal reports that the deal is potentially valued at 275.2 million.